Komori
Immuno-Biological Laboratories (4570) · InitiativeRestated

LPL Latex Automated Diagnostic Reagent Sales

First written in FY2016. 1 of 2 entries say "Restated". Latest entry: FY2017.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY20172016: 120162017: 12017
Same theme, other companies
Marketing approval and sales of an automated LPL latex diagnostic reagentA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2017RestatedAnnual report

    「The Company also developed a latex automated diagnostic reagent for LPL (lipoprotein lipase) and obtained marketing certification.」

    The development of and marketing certification for the LPL latex automated diagnostic reagent have been reconfirmed.
  2. FY2016First statedAnnual report

    「The Company developed its existing LPL measurement kit as a latex automated diagnostic reagent and obtained marketing approval. It aims to begin sales going forward.」

    The Company aims to sell the product compatible with automated analysis using the latex agglutination method after obtaining marketing approval.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Immuno-Biological Laboratories yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
LPL Latex Automated Diagnostic Reagent Sales | Immuno-Biological Laboratories Co.,Ltd. (4570) | Komori